Alphabiome specializes in using AI to analyze the human microbiome for genetic biomarkers that predict drug efficacy, advancing precision medicine.

Stately Bio develops cell therapies using a machine learning-powered live-cell imaging platform to enhance process development and quality control for biopharma companies.

Ataraxis AI develops AI-powered diagnostic tools to improve the accuracy and personalization of cancer treatment, starting with breast cancer diagnostics.

Ignota Labs uses AI technology to rescue and revive failing drug candidates by identifying and resolving drug toxicity issues.

Prompt AI is a startup that aims to democratize access to computer vision technology, allowing users to extract actionable knowledge from images and videos, thereby transforming visual data into valuable insights.

Ideogram is a Toronto-based startup that develops generative AI text-to-image technology to assist artists in accelerating their creative process.